FDA 483 - 3D Medical Manufacturing, Inc. - June 23, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of 3D Medical Manufacturing, Inc. in Riviera Beach, FL, revealed deficiencies in the firm's corrective and preventive action (CAPA) procedures. The company's process for escalating nonconformances to CAPAs was found inadequate, particularly concerning risk determination for legacy parts without clearly identified critical to quality (CTQ) dimensions. This could result in product defects, as evidenced by a customer complaint about sharp edges on a part causing sutures to break during surgery.
ID · 76b30195-c27a-417f-b5c4-b421c34cae68